cas 63460-47-9|| where to buy 2-(4-iodopentyl)isoindole-1,3-dione

Nom du produit:2-(4-iodopentyl)isoindole-1,3-dione

IUPAC Name:2-(4-iodopentyl)-2,3-dihydro-1H-isoindole-1,3-dione

Unité d'emballage	Stock disponible	Prix($)	Quantité

Pour une utilisation en R&D uniquement..

Formulaire de demande

Nom chimique

Numéro CAS

Quantité*

Spécifications requises*
(% d'analyse, qualité du matériau, etc.)

Nom du contact*

Email du contact*

Meanwhile I'd like to create a registered account on CHEMENU.COM with the above email.

I'd like to receive emails related to products with similar structures to 63460-47-9 regularly via the above email.

Notes supplémentaires

Verification code*

refresh

: N° CAS:63460-47-9; Formule moléculaire:C13H14INO2; Point de fusion:-; Code SMILES:O=C1N(CCCC(I)C)C(C2=C1C=CC=C2)=O; Densité:

: Numéro de catalogue:CM341453; Poids moléculaire:343.16; Point d'ébullition:; N° Mdl:; Stockage:

: Tafenoquine; 60 Degrees Pharmaceuticals recently announced it has entered into an agreement with Tufts Medical Center in Boston to conduct the world’s first clinical trial evaluating the efficacy and safety of tafenoquine in treating human babesiosis patients. The FDA has granted its investigational tafenoquine candidate orphan drug designation for the treatment of patients with acute babesiosis.
Tafenoquine was approved for malaria prophylaxis in 2018 in the United States as ARAKODA and in Australia as KODATEF. It is an antimalarial indicated for the prophylaxis of malaria in patients aged 18 years of age and older.